Reuters logo
10 months ago
BRIEF-Preliminary data from the ongoing open-label XmAB5871 phase 2 pilot study in IgG4-related disease to be presented at American College of Rheumatology (ACR) 2016 annual meeting
October 3, 2016 / 12:26 PM / 10 months ago

BRIEF-Preliminary data from the ongoing open-label XmAB5871 phase 2 pilot study in IgG4-related disease to be presented at American College of Rheumatology (ACR) 2016 annual meeting

1 Min Read

Oct 3 (Reuters) - Xencor Inc

* Preliminary data from the ongoing open-label XmAB5871 phase 2 pilot study in IgG4-related disease to be presented at American College of Rheumatology (ACR) 2016 annual meeting Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below